Minimal residual disease detection with tumor-specific CD160 correlates with event-free survival in chronic lymphocytic leukemia

In chronic lymphocytic leukemia (CLL), the detection of minimal residual disease (MRD) correlates with outcome in the trial setting. However, MRD assessment does not guide routine clinical management and its assessment remains complex. We incorporated detection of the B cell, tumor-specific antigen...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Blood Cancer J
Main Authors: Farren, T W, Giustiniani, J, Fanous, M, Liu, F, Macey, M G, Wright, F, Prentice, A, Nathwani, A, Agrawal, S G
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group 2015
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4314455/
https://ncbi.nlm.nih.gov/pubmed/25615279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2014.92
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker